Cancer in Norway 2021. Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer registry of Norway; 2022 [cited 2022 July 27]. Available from: https://www.kreftregisteret.no/globalassets/cancer-in-norway/2021/cin_report.pdf.
Key figures on cancer. Oslo: Cancer Registry of Norway; 2020 [cited 2022 June 29]. Available from: https://www.kreftregisteret.no/en/Temasider/key-figures-on-cancer/.
Chronic, late effects of cancer treatment: The consequences of a cure: Healio; 2020 [cited 2022 31. January]. Available from: https://www.healio.com/news/hematology-oncology/20200414/chronic-late-effects-of-cancer-treatment-the-consequences-of-a-cure.
Seneffekter etter kreftbehandling [late effects from cancer treatment] Oslo: Norwegian Directorate of Health; 2020. Available from: https://www.helsedirektoratet.no/rapporter/seneffekter-etter-kreftbehandling/Seneffekter%20etter%20kreftbehandling.pdf/_/attachment/inline/3d984c2a-7926-4d1a-a5f0-06d48fe7c95f:f3e498d059734ff34b013c1c206877e488e95600/Seneffekter%20etter%20kreftbehandling.pdf.
Helsedirektoratet. The Norwegian Directorate of Health: Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av kreft hos barn. Oslo: Helsedirektoratet. The Norwegian Directorate of Health; 2017.
Solem AG: "Ikke syk - Ikke frisk. (English: Neither ill - nor healthy." ). Plot, Dokumentar, Eksistens, dilemma. 2018;5(9):24–33.
Kirchhoff AC, Krull KR, Ness KK, Armstrong GT, Park ER, Stovall M, et al. Physical, mental, and neurocognitive status and employment outcomes in the childhood Cancer survivor study cohort. Cancer Epidemiol Biomark Prev. 2011;20(9):1838–49.
Ness KK, Gurney JG, Zeltzer LK, Leisenring W, Mulrooney DA, Nathan PC, et al. The impact of limitations in physical, executive, and emotional function on health-related quality of life among adult survivors of childhood cancer: a report from the childhood Cancer survivor study. Arch Phys Med Rehabil. 2008;89(1):128–36.
Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, et al. Physical performance limitations in the childhood Cancer survivor study cohort. J Clin Oncol. 2009;27(14):2382–9.
Article PubMed PubMed Central Google Scholar
Reinertsen KV, Loge JH, Brekke M, Kiserud CE. Chronic fatigue in adult cancer survivors. Tidsskrift for Den norske legeforening. 2017;137(21). https://doi.org/10.4045/tidsskr.17.0040.
Bissounauth V, Shatenstein B, Ghadirian P. Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview. Cancer Detect Prev. 2008;32:52–64.
Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577–92.
Bohn SH, Vandraas KF, Kiserud CE, Dahl AA, Thorsen L, Ewertz M, et al. Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivors. J Cancer Surviv. 2022:1–10.
Kiserud CE, Dahl AA, Fosså SD. Cancer survivorship in adults. In: Psycho-Oncology: Springer; 2018. p. 123–43.
Cancer in Norway 2020. Oslo: Cancer registry of Norway; 2021 [cited 2022 July 27]. Available from: https://healthtalkweb.s3.amazonaws.com/documents/Cancer_in_Norway_2020.pdf.
Syse A, Tretli S, Kravdal Ø. Cancer’s impact on employment and earnings—a population-based study from Norway. J Cancer Surviv. 2008;2(3):149–58.
Dahl AA, Fosså SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, et al. Employment status and work ability in long-term young adult Cancer survivors. J Adolesc Young Adult Oncol. 2019;8(3):304–11.
Johannesen TB, Langmark F, Wesenberg F, Lote K. Prevalence of Norwegian patients diagnosed with childhood cancer, their working ability and need of health insurance benefits. Acta Oncol. 2007;46(1):60–6.
Article PubMed CAS Google Scholar
Hansen F, Berntsen GR, Salamonsen A. Medical pluralism in the aftermath of cancer: health seeking actions and cancer patients’ shaping of trajectories to healing. Anthropol Med. 2020;27(3):330–46.
Saquib J, Madlensky L, Kealey S, Saquib N, Natarajan L, Newman VA, et al. Classification of CAM use and its correlates in patients with early-stage breast cancer. Integr Cancer Ther. 2011;10(2):138–47.
Act No. 64 of 27 June 2003 relating to the alternative treatment of disease, illness, etc. Oslo; 2003. Available from: https://app.uio.no/ub/ujur/oversatte-lover/data/lov-20030627-064-eng.pdf.
Pinto AC, De Azambuja E. Improving quality of life after breast cancer: dealing with symptoms. Maturitas. 2011;70(4):343–8.
Bower JE. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609.
Article PubMed PubMed Central CAS Google Scholar
Reinertsen KV, Engebraaten O, Loge JH, Cvancarova M, Naume B, Wist E, et al. Fatigue during and after breast cancer therapy—a prospective study. J Pain Symptom Manag. 2017;53(3):551–60.
JHv L, Abrahamsen AF, Ekeberg Ø, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol. 1999;17(1):253.
Brem S, Kumar NB. Management of treatment-related symptoms in patients with breast cancer. Clin J Oncol Nurs. 2011;15(1):63–71.
Ebede CC, Jang Y, Escalante CP. Cancer-related fatigue in cancer survivorship. Med Clin. 2017;101(6):1085–97.
Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, et al. Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol. 2020;31(6):713–23.
Article PubMed CAS Google Scholar
Finnegan-John J, Molassiotis A, Richardson A, Ream E. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue. Integr Cancer Ther. 2013;12(4):276–90.
Mahon SM, Carr E. Sleep-wake disturbances: common side effect. Clin J Oncol Nurs. 2021;25(6):33.
Mai QD, Jacobs AW, Schieman S. Precarious sleep? Nonstandard work, gender, and sleep disturbance in 31 European countries. Soc Sci Med. 2019;237:112424.
Kirserud C, Dahl A, Fosså S. Seneffekter etter kreftbehandling. I E. In: Schilchting & E. Wist (red.), editor. Kreftsykdommer–en basisbok for helsepersonell; 2018. p. 148–61.
Henneghan AM, Harrison T. Complementary and alternative medicine therapies as symptom management strategies for the late effects of breast cancer treatment. J Holist Nurs. 2015;33(1):84–97.
Szabo R, Marino J, Hickey M. Managing menopausal symptoms after cancer. Climacteric. 2019;22(6):572–8.
Article PubMed CAS Google Scholar
Eikeland SA, Smeland KB, Mols F, Fagerli UM, Bersvendsen HS, Kiserud CE, et al. Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life. Acta Oncol. 2021;60(7):911–20.
Article PubMed CAS Google Scholar
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain®. 2014;155(12):2461–70.
Hess SL, Dahl AA, Kiserud CE. Seneffekter etter kreftbehandling [Late effects from cancer treatment]. Sykepleien. 2018:1–11.
Swain SM, Arezzo JC. Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management. Clin Adv Hematol Oncol. 2008;6(6):455–67.
Brami C, Bao T, Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: a systematic review. Crit Rev Oncol Hematol. 2016;98:325–34.
Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes H, Jahn P, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306–19.
Article PubMed CAS Google Scholar
Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, et al. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. Eur J Cancer (Oxford, England : 1990). 2018;101:12–9.
GarciaMK CL, Guo Y, Zhou Y, You B, Chiang J, Orlowski RZ, et al. Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study. J Hematol Oncol. 2014;7:41.
Molassiotis A, Suen LKP, Cheng HL, Mok TSK, Lee SCY, Wang CH, et al. A randomized Assessor-blinded wait-list-controlled trial to assess the effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Integr Cancer Ther. 2019;18:1534735419836501.
Article PubMed PubMed Central Google Scholar
Han X, Wang L, Shi H, Zheng G, He J, Wu W, et al. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma. BMC Cancer. 2017;17(1):40.
Article PubMed PubMed Central Google Scholar
Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Psychiatry Med. 2010;40(2):163–81.
Breivik H, Cherny N, Collett B, De Conno F, Filbet M, Foubert A, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009;20(8):1420–33.
Article PubMed CAS Google Scholar
Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol. 2018;29:iv166–91.
Article PubMed CAS Google Scholar
Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32(36):4149–54.
Maindet C, Burnod A, Minello C, George B, Allano G, Lemaire A. Strategies of complementary and integrative therapies in cancer-related pain—attaining exhaustive cancer pain management. Support Care Cancer. 2019;27(8):3119–32. https://doi.org/10.1007/s00520-019-04829-7.
Bao Y, Kong X, Yang L, Liu R, Shi Z, Li W, et al. Complementary and alternative medicine for cancer pain: an overview of systematic reviews. Evid Based Complement Alternat Med. 2014;2014:170396. https://doi.org/10.1155/2014/170396.
留言 (0)